palpitations; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory agency. the reporter is the patient. regulatory number: gb-mhra-webcovid-202202161834525550. other case identifier(s): gb-mhra-adr 26611187. a patient (no qualifiers provided) received bnt162b2 (comirnaty), administration date 17oct2021 (lot number: fh0114) as dose 1, single for covid-19 immunisation. the patient's relevant medical history (no illnesses personally or history of heart conditions in the family) and concomitant medications were not reported. patient has not had symptoms associated with covid-19. the following information was reported: palpitations (medically significant) with onset 17oct2021, outcome "recovered" (30jan2022), described as "palpitations". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: negative, notes: no - negative covid-19 test. the clinical course was reported as following: for around 6 weeks each after the jab patient experienced totally random heart palpitations (i.e. not caused by exertion or change in mental state). they began on the day patient received jab and occurred daily for the first week or so and reduced slowly until patient stopped having them about 6 weeks after the jab. the onset lasted about a few minutes and was not painful but very worrying. no follow-up attempts are possible. no further information is expected.; sender's comments: linked report(s) : gb-pfizer inc-202200307816 same patient/drug/events and different dose

test name: covid-19 virus test; test result: negative ; comments: no - negative covid-19 test

na

na